TREATMENT OF CANCER ASCITES BY INTRAPERITONEAL ADMINISTRATION OF A STREPTOCOCCAL PREPARATION OK-432 WITH FRESH HUMAN-COMPLEMENT - ROLE OF COMPLEMENT-DERIVED CHEMOTACTIC FACTOR TO NEUTROPHILS

被引：12

作者：

KONDO, M

KATO, H

YOSHIKAWA, T

SUGINO, S

机构：

来源：

INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 1986年 / 8卷 / 07期

关键词：

D O I：

10.1016/0192-0561(86)90007-X

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：715 / +

页数：1

共 26 条

[1]

BACHMORTENSEN N, 1975, LANCET, V2, P499

[2] THE USE OF REPLACEMENT TRANSFUSION IN DISEASES OTHER THAN HEMOLYTIC DISEASE OF THE NEWBORN [J].

BESSIS, M .

BLOOD, 1949, 4 (04) :324-337

[3]

BLUM L, 1964, J IMMUNOL, V92, P61

[4] ANTIBODY AND COMPLEMENT-MEDIATED CYTOTOXICITY OF NUCLEATED CELLS - INHIBITION BY SERA OF PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA [J].

BOCK, GH ;

STITZEL, AE ;

RITTENHOUSE, KW ;

SPITZER, RE .

TRANSPLANTATION, 1978, 26 (06) :415-419

[5] ACTIVATION OF ALTERNATIVE COMPLEMENT PATHWAY BY LYMPHOBLASTOID CELL LINES DERIVED FROM PATIENTS WITH BURKITTS-LYMPHOMA AND INFECTIOUS-MONONUCLEOSIS [J].

BUDZKO, DB ;

LACHMANN, PJ ;

MCCONNELL, I .

CELLULAR IMMUNOLOGY, 1976, 22 (01) :98-109

[6]

CLARK RA, 1977, J IMMUNOL, V119, P1413

[7] HETEROCYTOTOXICITY OF HUMAN-SERUM .2. ROLE OF NATURAL ANTIBODY AND OF CLASSICAL AND ALTERNATIVE COMPLEMENT PATHWAYS [J].

EIDINGER, D ;

GERY, I ;

BELLO, E .

CELLULAR IMMUNOLOGY, 1977, 29 (01) :187-194

[8] HETEROCYTOTOXICITY OF HUMAN-SERUM .1. ACTIVATION OF ALTERNATIVE COMPLEMENT PATHWAY BY HETEROLOGOUS TARGET-CELLS [J].

EIDINGER, D ;

BELLO, E ;

MATES, A .

CELLULAR IMMUNOLOGY, 1977, 29 (01) :174-186

[9]

GALE RP, 1975, J IMMUNOL, V114, P1047

[10]

HAFEMAN DG, 1979, J IMMUNOL, V123, P55

← 1 2 3 →